Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells

Drawnel, Faye M., Boccardo, Stefano, Prummer, Michael, Delobel, Frédéric, Graff, Alexandra, Weber, Michael, Gérard, Régine, Badi, Laura +18 more·2014·Cell Reports
DOI 10.1016/j.celrep.2014.09.055

Cited by (256)

Items 101–200 of 256

  1. Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
    Emma Claire James, Eva Tomaskovic‐Crook, Jeremy Micah Crook · 2021 · International Journal of Molecular Sciences
  2. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection.
    Wen-Wen Deng, Xia Cao, Jing-Jing Chen, Zhi-Jian Zhang, Qing-Tong Yu, Yan Wang, Gen-Bao Shao, Jie Zhou, Xiang-Dong Gao, Jiang-Nan Yu et al. · 2015 · ACS Applied Materials and Interfaces
  3. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus
    Ling Fung Paul Tang, Hongkun Wang, Bing Dai, Xiaochen Wang, Danni Zhou, Jiaxi Shen, Fengfeng Guo, Jue Wang, Jing‐Jun Zhou, Hao Wang et al. · 2020 · Journal of Molecular and Cellular Cardiology
  4. Modeling the Effects of Maternal Diabetes on the Developing Human Heart Using Pluripotent Stem Cell–Derived Heart Organoids
    Yonatan R. Lewis‐Israeli, Mishref Abdelhamid, Isoken Nicholas Olomu, Aitor Aguirre · 2022 · Current Protocols
  5. Induced Pluripotent Stem Cell–Derived Endothelial Cells in Insulin Resistance and Metabolic Syndrome
    Ivan Carcamo‐Orive, Ngan Fong Huang, Thomas Quertermous, Joshua W. Knowles · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  6. Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models
    Ujang Purnama, Marcos Castro‐Guarda, Om Saswat Sahoo, Carolyn A. Carr · 2022 · Metabolites
  7. Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytes
    K. Ashley Fetterman, Malorie Blancard, Davi M. Lyra‐Leite, Carlos G. Vanoye, Hananeh Fonoudi, Mariam Jouni, Jean‐Marc DeKeyser, Brian Lenny, Yadav Sapkota, Alfred L. George et al. · 2024 · Cell Reports
  8. Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance
    Ilvy M. E. Geraets, Dipanjan Chanda, Florence H. J. van Tienen, Arthur van den Wijngaard, Rick Kamps, Dietbert Neumann, Yilin Liu, Jan F. C. Glatz, Joost J.F.P. Luiken, Miranda Nabben · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  9. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet
    Megan T. Quintana, Jun He, Jenyth Sullivan, Trisha Jean Grevengoed, Jonathan Cummings Schisler, Yipin Han, Joseph A. Hill, Cecelia Chrsitina Yates, William E. Stansfield, Rudo F. Mapanga et al. · 2015 · BMC Endocrine Disorders
  10. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology
    Ying Liu, Wenbin Deng · 2015 · Brain Research
  11. Disease modeling and functional screening using engineered heart tissue
    Richard J. Mills, Holly K. Voges, Enzo R. Porrello, James E. Hudson · 2017 · Current Opinion in Physiology
  12. Biofidelic dynamic compression of human cortical spheroids reproduces neurotrauma phenotypes
    Aaron R. Shoemaker, Ian E. Jones, Kira Jeffris, Gina Gabrielli, Alyssa G. Togliatti, Rajeswari Pichika, Eric Martin, Evangelos Kiskinis, Colin K. Franz, John D. Finan · 2021 · Disease Models & Mechanisms
  13. Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy
    Weiguang Luo, Mei He, Qizhi Luo, Yi Li · 2023 · Frontiers in Cardiovascular Medicine
  14. Patterns of Local and Systemic Cytokines in Bacterial Meningitis and its Relation with Severity and Long-Term Sequelae
    Federico Perdomo-Celis, Miguel A. Torres, Henry Ostos, Javier Gutierrez‐Achury, Victor Molano, Luis Fernando Durán, Guillermo Gonzalez, Carlos Fernando Narváez · 2015 · Biomarker Insights
  15. Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease
    Ayhan Atmanli, Ibrahim John Domian · 2016 · Trends in Cell Biology
  16. Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine
    Agustín Cota-Coronado, P. Berenice Ramírez-Rodríguez, Eduardo Padilla‐Camberos, éNstor F. Díaz, José Miguel Flores-Fernández, Daniela Ávila‐González, Nestor Emmanuel Diaz-Martinez · 2018 · Drug Discovery Today
  17. New insights into human beta cell biology using human pluripotent stem cells
    Nur Shabrina Amirruddin, Blaise Su Jun Low, Kok‐Onn Lee, E Shyong Tai, Adrian Kee Keong Teo · 2019 · Seminars in Cell and Developmental Biology
  18. Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects
    Keri Dame, Alexandre J. S. Ribeiro · 2020 · Experimental Biology and Medicine
  19. Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?
    Sevim Kahraman, Erin R. Okawa, R. Kulkarni · 2016 · Current Diabetes Reports
  20. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture
    Qing Zou, Mingjun Wu, Liwu Zhong, Zhaoxin Fan, Bo Zhang, Qiang Chen, Feng Ma · 2016 · PLoS ONE
  21. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    Matthew C. White, Li Pang, Xi Yang · 2016 · Food and Chemical Toxicology
  22. Modeling diabetic endothelial dysfunction with patient‐specific induced pluripotent stem cells
    Rayyan M. Gorashi, Nancy Rivera‐Bolanos, Caitlyn Dang, Cedric Chai, Beatrix Kovacs, Sara Alharbi, Syeda Subia Ahmed, Yogesh Goyal, Guillermo Antonio Ameer, Bin Jiang · 2023 · Bioengineering & Translational Medicine
  23. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing
    Mirella Ejiugwo, Yury A. Rochev, Georgina Gethin, Gerard M. O’Connor · 2021 · Tissue Engineering Part C Methods
  24. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective
    Mohamed M. Bekhite, Paul Christian Schulze · 2021 · Cells
  25. Microarray analysis of long non-coding RNA and mRNA expression profiles in diabetic cardiomyopathy using human induced pluripotent stem cell–derived cardiomyocytes
    Tarun Pant, Manoj K. Mishra, Xiaowen Bai, Zhi‐Dong Ge, Zeljko J. Bosnjak, Anuradha Dhanasekaran · 2018 · Diabetes and Vascular Disease Research
  26. Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics
    Silvia Crasto, Elisa Di Pasquale · 2018 · Frontiers in Cell and Developmental Biology
  27. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling
    Mayel Gharanei, Sanam Shafaattalab, Sarabjit S. Sangha, Marvin G. Gunawan, Zachary Laksman, Leif Hove‐Madsen, Glen F. Tibbits · 2021 · Methods
  28. G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling
    Nazanin F. Dolatshad, Nicola Hellen, Richard J. Jabbour, Siân E. Harding, Gábor Földes · 2015 · Frontiers in Cell and Developmental Biology
  29. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation
    Jiachen Lin, Yangzhong Zhou, Jiaqi Liu, Jia Chen, Wei‐Sheng Chen, Sen Zhao, Zhihong Wu, Nan Wu · 2017 · Journal of Cellular Biochemistry
  30. GLUT4 translocation and dispersal operate in multiple cell types and are negatively correlated with cell size in adipocytes
    Anna Magdalena Koester, Angéline Geiser, Peter R. T. Bowman, Sebastian van de Linde, Nikolaj Gadegaard, Nia J. Bryant, Gwyn W. Gould · 2022 · Scientific Reports
  31. Human pluripotent stem cell-based models of heart development and disease
    Gabriel Velichkova, Gergana D. Dobreva · 2023 · Cells and Development
  32. Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases
    Anita M. Chanana, June‐Wha Rhee, Joseph C. Wu · 2016 · Current Opinion in Cardiology
  33. Application of Cancer Cell Reprogramming Technology to Human Cancer Research
    Xiu-Yang Pan, Ming-Ho Tsai, Kenly Wuputra, Chia‐Chen Ku, Wen‐Hsin Lin, Ying‐Chu Lin, Shotaro Kishikawa, Michiya Noguchi, Shigeo Saito, Chang‐Shen Lin et al. · 2017 · Anticancer Research
  34. Fatty acid-based monolayer culture to promote in vitro neonatal rat cardiomyocyte maturation
    Giuseppe Isu, Diana Robles Diaz, Thomas Grussenmeyer, Emanuele Gaudiello, Friedrich Stefan Eckstein, Marijke Brink, Anna Marsano · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  35. Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell–Derived Cardiac Organoids
    Idan Refael Haim, Amit Gruber, Noam Kazma, Caroline Bashai, Hava Lichtig Kinsbruner, Oren Caspi · 2025 · Circulation Heart Failure
  36. Thousand and one amino acid protein kinase 1 suppression improves doxorubicin-induced cardiomyopathy by preventing cardiomyocyte death and dysfunction
    Takaomi Suga, Tomoya Kitani, Masaya Kogure, Masatsugu Oishi, Fumiaki Ito, Atsushi Hoshino, Takehiro Ogata, Koji Ikeda, Satoaki Matoba · 2025 · Cardiovascular Research
  37. Nitro-oleic acid enhances mitochondrial metabolism and ameliorates heart failure with preserved ejection fraction in mice
    Marion Müller, Torben Schubert, Cornelius Welke, Tibor Maske, Thomas Patschkowski, Elfi Donhauser, Jacqueline Heinen‐Weiler, Felix-Levin Hormann, Sven Heiles, Tina Johanna Schulz et al. · 2025 · Nature Communications
  38. Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
    Huensuk Kim, Christoph Schaniel · 2018 · Frontiers in Immunology
  39. Animal Research for Type 2 Diabetes Mellitus, Its Limited Translation for Clinical Benefit, and the Way Forward
    Zeeshan Ali, P. Charukeshi Chandrasekera, John J. Pippin · 2018 · Alternatives to Laboratory Animals
  40. The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes
    James W.S. Jahng, Mao Zhang, Joseph C. Wu · 2021 · Seminars in Cell and Developmental Biology
  41. Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions
    Mengmeng Wang, Degang Mo, Ning Zhang, Hai-Chu Yu · 2024 · Heliyon
  42. The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity
    Kornél Kistamás, Federica Lamberto, Raminta Vaičiulevičiūtė, Filipa Leal, Suchitra Muenthaisong, Luís Marte, Paula Subías-Beltrán, Aidas Alaburda, Dina N. Arvanitis, Melinda Zana et al. · 2024 · International Journal of Molecular Sciences
  43. Identification of biomarkers and mechanisms of diabetic cardiomyopathy using microarray data
    Hui Li, Xiaoyan Li, Jian Guo, Guifu Wu, Chunping Dong, Yaling Pang, Shan Gao, Yangwei Wang · 2018 · Cardiology Journal
  44. Who Will Win: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells for β Cell Replacement and Diabetes Disease Modeling?
    Elena F. Jacobson, Emmanuel S. Tzanakakis · 2018 · Current Diabetes Reports
  45. Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration
    Yike Huang, Ting Wang, Maria Elizabeth Urbina Lopez, Minoru Hirano, Anwarul Hasan, Su Ryon Shin · 2020 · Microphysiological Systems
  46. Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases
    Yann Ayotte, Ève Bernet, François Bilodeau, Mena Cimino, Dominic Gagnon, Marthe Lebughe, Maxime Mistretta, Paul Ogadinma, Sarah-Lisa Ouali, Aïssatou Aïcha Sow et al. · 2021 · ACS Chemical Biology
  47. Generation of Functional Cardiomyocytes from the Synoviocytes of Patients with Rheumatoid Arthritis via Induced Pluripotent Stem Cells
    Jaecheol Lee, Seung Min Jung, Antje Ebert, Haodi Wu, Sebastian Diecke, Youngkyun Kim, Hyoju Yi, Sung‐Hwan Park, Ji Hyeon Ju · 2016 · Scientific Reports
  48. Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening
    Anna P. Hnatiuk, Mark A. Mercola · 2019 · Cell stem cell
  49. Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes
    Alison Jessica Kriegel, Melanie Gartz, Muhammad Zeeshan Afzal, Willem J. de Lange, J. Carter Ralphe, Jennifer L. Strande · 2016 · Journal of Cardiovascular Translational Research
  50. The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons
    Ioana Neagoe, Chang Liu, Alexander Stumpf, Yanmei Lu, Dongping He, Ross Francis, Jun Chen, Paul H. Reynen, Moulay Hicham Alaoui-Ismaili, Hirokazu Fukui · 2018 · Stem Cell Research
  51. A Network-Biology Informed Computational Drug Repositioning Strategy to Target Disease Risk Trajectories and Comorbidities of Peripheral Artery Disease.
    Khader Shameer, Garrett T. Dow, Benjamin Scott Glicksberg, Kipp W. Johnson, Yi Ze, Max Tomlinson, Ben Readhead, Joel T. Dudley, Iftikhar J. Kullo · 2018 · Europe PMC (PubMed Central)
  52. Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.
    Shuo Cong, Chrishan J. A. Ramachandra, K.P. Myu Mai Ja, Jonathan Yap, WINSTON S. N. SHIM, Lai Wei, Derek John Hausenloy · 2020 · PubMed
  53. Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells
    Mario Pávez, Lukas Cyganek · 2022 · Frontiers in Cell and Developmental Biology
  54. Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses
    Brian Yu, Shane Rui Zhao, Christopher D. Yan, Mao Zhang, Joseph C. Wu · 2022 · Current Cardiology Reports
  55. Stem cells in cardiovascular diseases: turning bad days into good ones
    Maira Souza Oliveira Barreto, Felipe Saldanha‐Araújo, Alfredo Miranda Goes, Fabrício Falconi Costa, Juliana Lott Carvalho · 2017 · Drug Discovery Today
  56. Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases
    Zi Guo, Zhaohui Mo · 2021 · Life Sciences
  57. A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Diogo Crispim Nascimento Portella, Erik Aranha Rossi, Bruno Diaz Paredes, Tanira Matutino Bastos, Cássio Santana Meira, Carolina Kymie Vasques Nonaka, Daniela Nascimento Silva, Alex Cleber Improta Caria, Diogo Rodrigo Magalhães Moreira, Ana Cristina Lima Leite et al. · 2021 · Stem Cells International
  58. Intensive care for human hearts in pluripotent stem cell models
    Pelin Arabacilar Golforoush, Michael D. Schneider · 2020 · npj Regenerative Medicine
  59. Induced pluripotent stem cells as a platform to understand patient‐specific responses to opioids and anaesthetics
    Detlef Obal, Joseph C. Wu · 2020 · British Journal of Pharmacology
  60. Beyond genomics—technological advances improving the molecular characterization and precision treatment of heart failure
    Kory J. Lavine, Michael J. Greenberg · 2020 · Heart Failure Reviews
  61. Use of Hipsc to Explicate Genomic Predisposition to AnthrAcycline-Induced Cardiotoxicity
    Tarek Magdy, Paul W. Burridge · 2021 · Pharmacogenomics
  62. Modeling of endothelial cell dysfunction using human induced pluripotent stem cells derived from patients with end-stage renal disease
    Kyoung‐Woon Kim, Yoo‐Jin Shin, Bo‐Mi Kim, Sheng Cui, Eun Jeong Ko, Sun Woo Lim, Chul Woo Yang, Byung Ha Chung · 2021 · Kidney Research and Clinical Practice
  63. Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance
    Brian R. Berridge, Albert Eric Schultze, Jon Heyen, George H. Searfoss, R. Dustan Sarazan · 2016 · ILAR Journal
  64. Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture
    Nousheen Zahoor, Areej Arif, Muhammad Shuaib, Kai Jin, Bichun Li, Zeyu Li, Xiaomeng Pei, Xilin Zhu, Qisheng Zuo, Yingjie Niu et al. · 2024 · Veterinary Sciences
  65. Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review
    Sama Thiab, Juberiya Mohammed Azeez, Alekya Devi Anala, Moksha Nanda, Somieya Khan, Alexandra E. Butler, Manjula Nandakumar · 2025 · Cells
  66. Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges
    Jia‐Peng Li, Meng‐Meng Fu, Xiao‐Xue Li, Ming Xu · 2024 · British Journal of Pharmacology
  67. Myogenin suppresses apoptosis induced by angiotensin II in human induced pluripotent stem cell-derived cardiomyocytes
    Qiang Gao, PING H. WANG, Hailong Qiu, Bin Qiu, Wenlong Yi, Wenchang Tu, Bin Lin, Daoheng Sun, Rong Zeng, Meiping Huang et al. · 2021 · Biochemical and Biophysical Research Communications
  68. Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytes
    Dennis Schade, Lauren Drowley, Qing‐Dong Wang, Alleyn T. Plowright, Boris Greber · 2022 · Bioorganic & Medicinal Chemistry
  69. The potential of human induced pluripotent stem cells for modelling diabetic wound healing in vitro
    Patricia E. Martin, Erin M. O’Shaughnessy, Catherine Wright, Annette Graham · 2018 · Clinical Science
  70. Human embryonic stem cells as anin vitromodel for studying developmental origins of type 2 diabetes
    Andy Chun-Hang Chen, Kai Fai Lee, William S.B. Yeung, Yin Lau Lee · 2020 · World Journal of Stem Cells
  71. Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
    Takeshi Tokuyama, Razan Elfadil Ahmed, Nawin Chanthra, Tatsuya Anzai, Hideki Uosaki · 2021 · Biology
  72. Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
    Abhishikt David Solomon, Swarna Dabral, Raman Gulab Brajesh, Billy W. Day, Matea Juric, Jacek Zielonka, Zeljko J. Bosnjak, Tarun Pant · 2025 · International Journal of Molecular Sciences
  73. Construction of engineered cardiac tissue on a heart-on-a-chip device enables modeling of arrhythmogenic right ventricular cardiomyopathy
    Kai-Yun Qu, Hongyi Cheng, Li Qiao, Jincheng Jiao, Shiqi Chang, Xiafeng Peng, Chang Cui, Feng Zhang, Ning‐Ping Huang · 2025 · Biosensors and Bioelectronics
  74. Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?
    Peter R. T. Bowman, Godfrey L. Smith, Gwyn W. Gould · 2021 · PeerJ
  75. Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
    Pranav Machiraju, Steven C. Greenway · 2019 · World Journal of Stem Cells
  76. Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health
    Elizabeth M. O’Day, Leticia Hosta‐Rigau, Diego A. Oyarzún, Hideyuki Okano, Vı́ctor de Lorenzo, Conrad von Kameke, Habiba S. AlSafar, Cong Cao, Guo‐Qiang Chen, Weizhi Ji et al. · 2018 · Biotechnology Journal
  77. Phenotypic Screening
    Alleyn T. Plowright, Lauren Drowley · 2017 · Annual reports in medicinal chemistry
  78. Biosensor-based profiling to track cellular signalling in patient-derived models of dilated cardiomyopathy.
    Kyla Bourque, Cara Hawey, Alyson Jiang, Grace R Mazarura, T. Hébert · 2022 · Cellular Signalling
  79. Induced pluripotent stem cell-based models: Are we ready for that heart in a dish?
    Irene Bissoli, Stefania D’Adamo, Carla Pignatti, Giulio Agnetti, Flavio Flamigni, Silvia Cetrullo · 2023 · Frontiers in Cell and Developmental Biology
  80. Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy
    Koray N. Potel, Victoria A. Cornelius, Andrew Yacoub, Ali Chokr, Clare Lubov Donaghy, Sophia Kelaini, Magdalini Eleftheriadou, Andriana Margariti · 2023 · Frontiers in Cardiovascular Medicine
  81. Construction of 3D hierarchical tissue platforms for modeling diabetes
    Myungji Kim, Jinah Jang · 2021 · APL Bioengineering
  82. Administration of stem cells against cardiovascular diseases with a focus on molecular mechanisms: Current knowledge and prospects
    Mohammad Karimian, Negar Nouri, Leila Vafadar Ghasemi, Amir Hossein Mohammadi, Mohaddeseh Behjati · 2023 · Tissue and Cell
  83. Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heart
    Jialing Tang, Nanyoung Yoon, Keith Dadson, Hye Kyoung Sung, Yubin Lei, Thanh Q. Dang, Wing Yan Chung, Saher Ahmed, Ali A. Abdul Sater, Jun Wu et al. · 2024 · Autophagy Reports
  84. Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies
    Dilip Thomas, Phillip Chung-Ming Yang, Joseph C. Wu, Nazish Sayed · 2025 · Journal of Molecular and Cellular Cardiology
  85. Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target
    Abhishek Dattani, Anvesha Singh, Gerry Patrick McCann, Gaurav Singh Gulsin · 2023 · Journal of Cardiovascular Development and Disease
  86. Histone Deacetylase Inhibitors Restore the Odontogenic Differentiation Potential of Dental Pulp Stem Cells under Hyperglycemic Conditions
    Mahshid Hodjat, Fatemeh Farshad, Mahdi Gholami, Mohammad Reza Abdollahi, Khandakar A.S.M. Saadat · 2024 · Current Stem Cell Research & Therapy
  87. A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin
    Lin Cai, Yuxin Zhao, Zilong Li, Liping Xiao, Yifan Wu, Shiya Wang, Qian Liu, Yida Ye, Yuxuan Guo, Donghui Zhang · 2025 · Advanced Science
  88. Beyond Family: Modeling Non-hereditary Heart Diseases With Human Pluripotent Stem Cell-Derived Cardiomyocytes
    Sebastian Martewicz, Michael Magnussen, Nicola Elvassore · 2020 · Frontiers in Physiology
  89. Human pluripotent stem cell–based cardiovascular disease modeling and drug discovery
    Ge Liu, Zhun Liu, Nan Cao · 2021 · Pflügers Archiv - European Journal of Physiology
  90. Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review
    Osonuga, Ayokunle, Olawade, David B., Gore, Manisha, Rotifa, Oluwayomi B., Egbon, Eghosasere, Chinwah, Viviane, Boussios, Stergios · 2025 · Annals of Translational Medicine
  91. Computational and stem cell biology
    Rajiv Kumar, Agnieszka Maria Jastrzębska, Magali Cucchiarin, Neelam Chhillar, Mitrabasu Chhillar · 2024 · Elsevier eBooks
  92. Advanced in vitro cardiac models for drug evaluation: integration of organoids, engineered tissues, and microphysiological systems
    Young Hyun Kim, Young Hoon Son, Yuri Choi, Min Suk Kim, Sung‐Jin Park, Keel Yong Lee · 2026 · Microsystems & Nanoengineering
  93. Research Progress towards the Effects of Fatty Acids on the Differentiation and Maturation of Human Induced Pluripotent Stem Cells into Cardiomyocytes
    Zhen Gao, Fan Zhou, Junsheng MU · 2023 · Reviews in Cardiovascular Medicine
  94. Revolutionising Cardio-Oncology Care with Precision Genomics
    Jun Hua Chong, Charles T. H. Chuah, Caroline Guat Lay Lee · 2025 · International Journal of Molecular Sciences
  95. Quantitative proteomics analysis revealed the potential role of lncRNA Ftx in cardiomyocytes
    Xiangfei Sun, Ying Jiang, Qingbao Li, Qi Tan, Mingliang Dong, Bi’e Cai, Di Zhang, Qi Zhao · 2023 · Proteome Science
  96. Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology
    N. Rawat, Manoj Kumar Singh · 2017 · Veterinary World
  97. Glucagon‐Like Peptide‐1 (GLP‐1) Rescue Diabetic Cardiac Dysfuntions in Human iPSC‐Derived Cardiomyocytes
    Ying Zhou, Shu-Ting Huang, LI CHENG-WU, Yue Qiao, Qing Liu, Taotao Chen, Jiaxian Wang, Yu Liu · 2022 · Advanced Biology
  98. Induced Pluripotent Stem Cells: Advances and Applications in Regenerative Medicine
    Igor V. Kizub, Andrii I. Rozhok, Ganna Bilousova · 2023 · Biochemistry
  99. Detecting and measuring of GPCR signaling – comparison of human induced pluripotent stem cells and immortal cell lines
    Gaoxian Chen, Detlef Obal · 2023 · Frontiers in Endocrinology
  100. Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype
    Filip Roudnicky, Yanjun Lan, Max Friesen, Gregor Dernick, Jitao David Zhang, Andreas A. Staempfli, Natalie Bordag, Antje Wagner-Golbs, Klaus Christensen, Martin Ebeling et al. · 2019 · International Journal of Molecular Sciences